Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-06

AUTHORS

Marc C. Chamberlain, Jeffrey Raizer

ABSTRACT

OBJECTIVE: A case series of gliomas treated with alkylator-based chemotherapy who subsequently developed myelodysplastic syndrome (tMDS) or acute myelocytic leukemia (AML). BACKGROUND: Alkylator-based chemotherapy is recognized to be leukemogenic; however, it is infrequently described as a delayed consequence of anti-glioma treatment. METHODS: Seven patients (4 men; 3 women) ages 34-69 years (median 44), with gliomas (3 Grade 2; 4 Grade 3) were treated with surgery, all but one with involved-field radiotherapy and all with alkylator-based chemotherapy (temozolomide; 6 patients, nitrosoureas; 5 patients, both agents; 5 patients). RESULTS: Exposure to alkylator-based chemotherapy ranged from 8 to 30 months (median 24). The diagnosis of tMDS was determined by bone marrow biopsy in 7 patients. Seven patients showed chromosomal abnormalities consistent with chemotherapy induced MDS. Three patients were diagnosed with AML as well (in two determined by bone marrow and one at autopsy). Interval from last chemotherapy exposure to diagnosis of tMDS/AML ranged from 3 to 31 months (median 24 months). Two patients were treated with bone marrow transplantation and 5 received supportive care only. Five patients have died, 2 as a consequence of recurrent brain tumor, 1 as a complication of transplantation, and 2 due to AML. CONCLUSIONS: Although rare, induction of tMDS/AML following extended use of alkylator-based chemotherapy may become more relevant with the evolving practice to treat gliomas for protracted periods. Future work to determine at risk patients would be important. More... »

PAGES

229-232

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-008-9764-5

DOI

http://dx.doi.org/10.1007/s11060-008-9764-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030980196

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19099199


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Alkylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dacarbazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myelodysplastic Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitrosourea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reoperation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survivors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Fred Hutchinson Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.270240.3", 
          "name": [
            "Department of Neurology and Neurological Surgery, University of Washington, Washington, DC, USA", 
            "Fred Hutchinson Cancer Center, Seattle Cancer Care, Alliance 825 Eastlake Avenue E, Mailstop: G4-940, PO Box 19023, 98109-1023, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chamberlain", 
        "givenName": "Marc C.", 
        "id": "sg:person.01326261166.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern University", 
          "id": "https://www.grid.ac/institutes/grid.16753.36", 
          "name": [
            "Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raizer", 
        "givenName": "Jeffrey", 
        "id": "sg:person.010677556177.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010677556177.51"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1212/wnl.56.1.118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002499445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.56.1.118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002499445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.10.169", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009174773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-004-2028-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017526537", 
          "https://doi.org/10.1007/s11060-004-2028-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1011878214861", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020813811", 
          "https://doi.org/10.1023/a:1011878214861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000065718", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024124197"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.3414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025173270"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(90)90096-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027872679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1215/15228517-2006-003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028514369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.6078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030668601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198508293130911", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036712812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006175831785", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041043641", 
          "https://doi.org/10.1023/a:1006175831785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2176/nmc.42.170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048534183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2176/nmc.42.170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048534183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2176/nmc.42.170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048534183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa043330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052112015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008382516636", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056303625"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.01.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203257"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.12.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000127617.89363.84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000127617.89363.84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000127617.89363.84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000127617.89363.84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.2.340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.2.340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.2.340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.2.340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.11.3389", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074545742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074658183", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.2.509", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074768339"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-06", 
    "datePublishedReg": "2009-06-01", 
    "description": "OBJECTIVE: A case series of gliomas treated with alkylator-based chemotherapy who subsequently developed myelodysplastic syndrome (tMDS) or acute myelocytic leukemia (AML).\nBACKGROUND: Alkylator-based chemotherapy is recognized to be leukemogenic; however, it is infrequently described as a delayed consequence of anti-glioma treatment.\nMETHODS: Seven patients (4 men; 3 women) ages 34-69 years (median 44), with gliomas (3 Grade 2; 4 Grade 3) were treated with surgery, all but one with involved-field radiotherapy and all with alkylator-based chemotherapy (temozolomide; 6 patients, nitrosoureas; 5 patients, both agents; 5 patients).\nRESULTS: Exposure to alkylator-based chemotherapy ranged from 8 to 30 months (median 24). The diagnosis of tMDS was determined by bone marrow biopsy in 7 patients. Seven patients showed chromosomal abnormalities consistent with chemotherapy induced MDS. Three patients were diagnosed with AML as well (in two determined by bone marrow and one at autopsy). Interval from last chemotherapy exposure to diagnosis of tMDS/AML ranged from 3 to 31 months (median 24 months). Two patients were treated with bone marrow transplantation and 5 received supportive care only. Five patients have died, 2 as a consequence of recurrent brain tumor, 1 as a complication of transplantation, and 2 due to AML.\nCONCLUSIONS: Although rare, induction of tMDS/AML following extended use of alkylator-based chemotherapy may become more relevant with the evolving practice to treat gliomas for protracted periods. Future work to determine at risk patients would be important.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-008-9764-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "93"
      }
    ], 
    "name": "Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia", 
    "pagination": "229-232", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "93968c134ed2da3e01365b606378cfc4f3607e5c7efdfa8de8c21609b1839885"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19099199"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-008-9764-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030980196"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-008-9764-5", 
      "https://app.dimensions.ai/details/publication/pub.1030980196"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000532.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-008-9764-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-008-9764-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-008-9764-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-008-9764-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-008-9764-5'


 

This table displays all metadata directly associated to this object as RDF triples.

213 TRIPLES      21 PREDICATES      67 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-008-9764-5 schema:about N0255a53581cc4947bcfc1030233d831e
2 N329e4797db8b42d295b5b83130a26551
3 N48f21ec5402c448eb458bbf6f52a7e0c
4 N4c2d95abd3f34f9882c991c848cf9a6f
5 N4d6b98e220cc451a8963efb49a6b5d0a
6 N50b090b46a5148098b91b2f675118644
7 N50e92263760744a493d65a3244f49bd4
8 N604caccb92af4063b1b0d03bad8eaca9
9 N606b39ccaffb49019402117b7b8c2fe5
10 N8dc157834d9a4e779af1edc5c3bfd1bc
11 N920c0a130dcd44fe8d195847d931339b
12 N994f4e39c4974b899e7a156b285e2b9e
13 Nab605ca6ec12463eaa31329702cc26cb
14 Nb8638495a19946e19732cf714e438c8b
15 Nb8a66d2f8c844885baafaad0cc86aee8
16 Nee3a8e725c6b4fcbb3fd473408e2c8bb
17 Nf8bbfda1f4fb49e2af817615b780689f
18 anzsrc-for:11
19 anzsrc-for:1112
20 schema:author Ne820ec7e26dc400280390622a36358e0
21 schema:citation sg:pub.10.1007/s11060-004-2028-0
22 sg:pub.10.1023/a:1006175831785
23 sg:pub.10.1023/a:1011878214861
24 https://app.dimensions.ai/details/publication/pub.1074658183
25 https://doi.org/10.1016/0360-3016(90)90096-3
26 https://doi.org/10.1023/a:1008382516636
27 https://doi.org/10.1056/nejm198508293130911
28 https://doi.org/10.1056/nejmoa043330
29 https://doi.org/10.1159/000065718
30 https://doi.org/10.1200/jco.1999.17.11.3389
31 https://doi.org/10.1200/jco.2001.19.2.509
32 https://doi.org/10.1200/jco.2003.01.009
33 https://doi.org/10.1200/jco.2003.12.015
34 https://doi.org/10.1200/jco.2004.10.169
35 https://doi.org/10.1200/jco.2005.04.3414
36 https://doi.org/10.1200/jco.2005.04.6078
37 https://doi.org/10.1212/01.wnl.0000127617.89363.84
38 https://doi.org/10.1212/wnl.56.1.118
39 https://doi.org/10.1212/wnl.57.2.340
40 https://doi.org/10.1215/15228517-2006-003
41 https://doi.org/10.2176/nmc.42.170
42 schema:datePublished 2009-06
43 schema:datePublishedReg 2009-06-01
44 schema:description OBJECTIVE: A case series of gliomas treated with alkylator-based chemotherapy who subsequently developed myelodysplastic syndrome (tMDS) or acute myelocytic leukemia (AML). BACKGROUND: Alkylator-based chemotherapy is recognized to be leukemogenic; however, it is infrequently described as a delayed consequence of anti-glioma treatment. METHODS: Seven patients (4 men; 3 women) ages 34-69 years (median 44), with gliomas (3 Grade 2; 4 Grade 3) were treated with surgery, all but one with involved-field radiotherapy and all with alkylator-based chemotherapy (temozolomide; 6 patients, nitrosoureas; 5 patients, both agents; 5 patients). RESULTS: Exposure to alkylator-based chemotherapy ranged from 8 to 30 months (median 24). The diagnosis of tMDS was determined by bone marrow biopsy in 7 patients. Seven patients showed chromosomal abnormalities consistent with chemotherapy induced MDS. Three patients were diagnosed with AML as well (in two determined by bone marrow and one at autopsy). Interval from last chemotherapy exposure to diagnosis of tMDS/AML ranged from 3 to 31 months (median 24 months). Two patients were treated with bone marrow transplantation and 5 received supportive care only. Five patients have died, 2 as a consequence of recurrent brain tumor, 1 as a complication of transplantation, and 2 due to AML. CONCLUSIONS: Although rare, induction of tMDS/AML following extended use of alkylator-based chemotherapy may become more relevant with the evolving practice to treat gliomas for protracted periods. Future work to determine at risk patients would be important.
45 schema:genre research_article
46 schema:inLanguage en
47 schema:isAccessibleForFree false
48 schema:isPartOf N29391eabe26c4cffac42f21a86c9dfde
49 Naea96c8a908c4bc7b3fb3e3e1aeb1d83
50 sg:journal.1094205
51 schema:name Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia
52 schema:pagination 229-232
53 schema:productId N2a61be7673554e88b7655c0cc73191a4
54 N4bde726e0c5e44b1ae8659b0181fbd58
55 N86a148ab8f30492489906d240f1bea13
56 Nccad7868204a415283c3c06aa99b8ce0
57 Ne64bd204b5ff47e7a1368d1d924ae41b
58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030980196
59 https://doi.org/10.1007/s11060-008-9764-5
60 schema:sdDatePublished 2019-04-10T15:05
61 schema:sdLicense https://scigraph.springernature.com/explorer/license/
62 schema:sdPublisher Nbdb369c9ebfa481b98ed71e5722dab57
63 schema:url http://link.springer.com/10.1007%2Fs11060-008-9764-5
64 sgo:license sg:explorer/license/
65 sgo:sdDataset articles
66 rdf:type schema:ScholarlyArticle
67 N0255a53581cc4947bcfc1030233d831e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Survivors
69 rdf:type schema:DefinedTerm
70 N29391eabe26c4cffac42f21a86c9dfde schema:volumeNumber 93
71 rdf:type schema:PublicationVolume
72 N2a61be7673554e88b7655c0cc73191a4 schema:name nlm_unique_id
73 schema:value 8309335
74 rdf:type schema:PropertyValue
75 N329e4797db8b42d295b5b83130a26551 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Brain Neoplasms
77 rdf:type schema:DefinedTerm
78 N48f21ec5402c448eb458bbf6f52a7e0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Dacarbazine
80 rdf:type schema:DefinedTerm
81 N4bde726e0c5e44b1ae8659b0181fbd58 schema:name dimensions_id
82 schema:value pub.1030980196
83 rdf:type schema:PropertyValue
84 N4c2d95abd3f34f9882c991c848cf9a6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Aged
86 rdf:type schema:DefinedTerm
87 N4d6b98e220cc451a8963efb49a6b5d0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Humans
89 rdf:type schema:DefinedTerm
90 N50b090b46a5148098b91b2f675118644 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Follow-Up Studies
92 rdf:type schema:DefinedTerm
93 N50e92263760744a493d65a3244f49bd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Male
95 rdf:type schema:DefinedTerm
96 N604caccb92af4063b1b0d03bad8eaca9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Time Factors
98 rdf:type schema:DefinedTerm
99 N606b39ccaffb49019402117b7b8c2fe5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Adult
101 rdf:type schema:DefinedTerm
102 N86a148ab8f30492489906d240f1bea13 schema:name pubmed_id
103 schema:value 19099199
104 rdf:type schema:PropertyValue
105 N8dc157834d9a4e779af1edc5c3bfd1bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Female
107 rdf:type schema:DefinedTerm
108 N920c0a130dcd44fe8d195847d931339b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Survival Analysis
110 rdf:type schema:DefinedTerm
111 N994f4e39c4974b899e7a156b285e2b9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Middle Aged
113 rdf:type schema:DefinedTerm
114 Na02e034e920c46088fef367b8eea37cc rdf:first sg:person.010677556177.51
115 rdf:rest rdf:nil
116 Nab605ca6ec12463eaa31329702cc26cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Nitrosourea Compounds
118 rdf:type schema:DefinedTerm
119 Naea96c8a908c4bc7b3fb3e3e1aeb1d83 schema:issueNumber 2
120 rdf:type schema:PublicationIssue
121 Nb8638495a19946e19732cf714e438c8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Reoperation
123 rdf:type schema:DefinedTerm
124 Nb8a66d2f8c844885baafaad0cc86aee8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Antineoplastic Agents, Alkylating
126 rdf:type schema:DefinedTerm
127 Nbdb369c9ebfa481b98ed71e5722dab57 schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 Nccad7868204a415283c3c06aa99b8ce0 schema:name doi
130 schema:value 10.1007/s11060-008-9764-5
131 rdf:type schema:PropertyValue
132 Ne64bd204b5ff47e7a1368d1d924ae41b schema:name readcube_id
133 schema:value 93968c134ed2da3e01365b606378cfc4f3607e5c7efdfa8de8c21609b1839885
134 rdf:type schema:PropertyValue
135 Ne820ec7e26dc400280390622a36358e0 rdf:first sg:person.01326261166.36
136 rdf:rest Na02e034e920c46088fef367b8eea37cc
137 Nee3a8e725c6b4fcbb3fd473408e2c8bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Glioma
139 rdf:type schema:DefinedTerm
140 Nf8bbfda1f4fb49e2af817615b780689f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Myelodysplastic Syndromes
142 rdf:type schema:DefinedTerm
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
147 schema:name Oncology and Carcinogenesis
148 rdf:type schema:DefinedTerm
149 sg:journal.1094205 schema:issn 0167-594X
150 1573-7373
151 schema:name Journal of Neuro-Oncology
152 rdf:type schema:Periodical
153 sg:person.010677556177.51 schema:affiliation https://www.grid.ac/institutes/grid.16753.36
154 schema:familyName Raizer
155 schema:givenName Jeffrey
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010677556177.51
157 rdf:type schema:Person
158 sg:person.01326261166.36 schema:affiliation https://www.grid.ac/institutes/grid.270240.3
159 schema:familyName Chamberlain
160 schema:givenName Marc C.
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36
162 rdf:type schema:Person
163 sg:pub.10.1007/s11060-004-2028-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017526537
164 https://doi.org/10.1007/s11060-004-2028-0
165 rdf:type schema:CreativeWork
166 sg:pub.10.1023/a:1006175831785 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041043641
167 https://doi.org/10.1023/a:1006175831785
168 rdf:type schema:CreativeWork
169 sg:pub.10.1023/a:1011878214861 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020813811
170 https://doi.org/10.1023/a:1011878214861
171 rdf:type schema:CreativeWork
172 https://app.dimensions.ai/details/publication/pub.1074658183 schema:CreativeWork
173 https://doi.org/10.1016/0360-3016(90)90096-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027872679
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1023/a:1008382516636 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056303625
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1056/nejm198508293130911 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036712812
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1056/nejmoa043330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052112015
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1159/000065718 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024124197
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1200/jco.1999.17.11.3389 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074545742
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1200/jco.2001.19.2.509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074768339
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1200/jco.2003.01.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203257
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1200/jco.2003.12.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203991
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1200/jco.2004.10.169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009174773
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1200/jco.2005.04.3414 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025173270
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1200/jco.2005.04.6078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030668601
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1212/01.wnl.0000127617.89363.84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064346031
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1212/wnl.56.1.118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002499445
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1212/wnl.57.2.340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064379939
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1215/15228517-2006-003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028514369
204 rdf:type schema:CreativeWork
205 https://doi.org/10.2176/nmc.42.170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048534183
206 rdf:type schema:CreativeWork
207 https://www.grid.ac/institutes/grid.16753.36 schema:alternateName Northwestern University
208 schema:name Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
209 rdf:type schema:Organization
210 https://www.grid.ac/institutes/grid.270240.3 schema:alternateName Fred Hutchinson Cancer Research Center
211 schema:name Department of Neurology and Neurological Surgery, University of Washington, Washington, DC, USA
212 Fred Hutchinson Cancer Center, Seattle Cancer Care, Alliance 825 Eastlake Avenue E, Mailstop: G4-940, PO Box 19023, 98109-1023, Seattle, WA, USA
213 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...